Abstract
Background: Genes play a critical role in spermatogenesis and the maintenance of fertility, potentially serving as biomarkers for clinical diagnosis. However, the molecular regulation of these biological processes in infertility remains poorly understood. Methods: This study identified associated genes by reanalyzing GEO datasets (GSE45885, GSE45887, and GSE9210) and a validation dataset (GSE4797). Differential gene expression (DEG) analysis was performed using the limma package, while GO and KEGG pathway enrichment analyses utilized clusterProfiler. Protein-protein interaction (PPI) networks were constructed via the STRING database, and mRNA-TF interactions were predicted using miRWalk. Finally, hub gene expression levels were validated using TCGA data in GEPIA. Results: Several shared genes were significantly associated with azoospermia. Two genes, KIF2C and TEKT2, were effectively screened and validated in spermatozoa of infertile men (GSE4797) categorized by Johnsen score. Both genes were significantly downregulated in infertile men. A regulatory TF-miRNA-target gene network suggested that the KIF2C-miRNA-TF axis may be functional in infertility. Conclusions: This study improves our understanding of azoospermia mechanisms and identifies potential diagnostic biomarkers and therapeutic targets.
Introduction
Male infertility is a complex condition affecting approximately 7% of the global male population. Azoospermia, the complete absence of sperm in the ejaculate, represents one of its most severe forms. While genetic factors contribute to at least 15% of cases, the specific molecular pathways involved are not fully elucidated. Furthermore, clinical evidence suggests a link between male infertility and an increased risk of testicular carcinoma. This study aims to identify the genetic "common denominator" linking impaired spermatogenesis to oncogenic changes, providing potential biomarkers for diagnosis and therapy.
Methods and Datasets
The researchers employed a bioinformatics-based meta-analysis approach to identify key regulatory genes. The workflow involved:
- Differential Gene Expression (DEG) Analysis: Comparing gene expression between healthy controls and azoospermia patients across three independent datasets.
- Functional Enrichment: Identifying biological themes such as microtubule binding and cell cycle regulation.
- Network Biology: Constructing PPI networks to identify "hub genes"—central players in biological processes.
- Regulatory Mapping: Predicting microRNA (miRNA) and transcription factor (TF) control over hub genes.
The study utilized several key resources from the Gene Expression Omnibus (GEO), summarized in the table below.
Validation was performed using dataset GSE4797, which categorizes samples by the Johnsen score (a histological grading of spermatogenesis), and cancer data from The Cancer Genome Atlas (TCGA).
Key Results and Insights
The analysis initially identified 1,396 DEGs, which were narrowed down to 27 shared genes across the primary datasets. From these, 12 hub genes were identified, including ANLN, CCNB1, and CENPF.
The Role of KIF2C and TEKT2
Two genes, KIF2C and TEKT2, stood out during validation. In the GSE4797 dataset, both showed a statistically significant correlation with the Johnsen score ($p < 0.05$).
- KIF2C (Kinesin-13 family): Known for depolymerizing microtubules, it likely ensures correct chromosome connection during cell division and assists in DNA damage repair. Its downregulation may lead to the arrest of sperm development.
- TEKT2 (Tektin protein): Essential for the structural integrity of the sperm tail (flagella). The study found that as fertility quality (Johnsen score) decreased, TEKT2 expression also declined.
The Infertility-Cancer Link
All 12 hub genes identified were differentially expressed in cancerous testicular tissue compared to normal tissue ($|logFC| > 1, p < 0.01$). This suggests that the molecular failures preventing sperm formation might also facilitate uncontrolled cellular growth leading to tumors.
Conclusion
By identifying KIF2C and TEKT2 as critical biomarkers, this study provides a foundation for understanding the shared pathways between male infertility and testicular cancer. While these computational results are robust, further "wet lab" validation, such as CRISPR-based functional studies or clinical cohort analysis, is necessary to confirm these mechanisms and explore their potential in therapeutic interventions.
Summary updated